Treatment of herpes zoster ophthalmicus with methanesulphonate of hydrogenated ergotamine.
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004878:Ergotamine; D006562:Herpes Zoster; D006563:Herpes Zoster Ophthalmicus; D006801:Humans; D008698:Mesylates
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D008698:Mesylates; C045880:methanesulfonic acid; D004878:Ergotamine
ERGOT ALKALOIDS/therapeutic use; HERPES ZOSTER